Distinguishing the lipid profile of GCK-MODY patients and its correlation with hsCRP levels

被引:1
|
作者
Ping, Fan [1 ]
Fu, Junling [1 ]
Xiao, Xinhua [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Endocrinol, Key Lab Endocrinol,Natl Hlth Commiss NHC, Beijing, Peoples R China
来源
关键词
maturity-onset diabetes of the young; glucokinase; cardiovascular protection; high-sensitivity C-reactive protein; serum lipid profile; PROTEIN; DISEASE; RISK;
D O I
10.3389/fendo.2022.1024431
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsGlucokinase-maturity-onset diabetes of the young (GCK-MODY) is the most common monogenic diabetes in China. We have previously reported on the low levels of high-sensitivity C-reactive protein (hsCRP) in patients with GCK-MODY. In this study, we further explored the correlation between the serum lipid profiles and hsCRP levels of patients with different types of diabetes. We also proposed to determine the possible mechanism of macrovascular protection in GCK genetic variants. MethodsThe serum lipid profiles of the GCK-MODY group (n = 50) were compared with those of the hepatocyte nuclear factor-1 alpha (HNF1A)-MODY group (n = 19), the type 1 diabetes (T1D) group (n = 50), and the type 2 diabetes (T2D) group (n = 54). The associations between the lipid compositions and the hsCRP levels in each group were also explored. ResultsElevated levels of high-density lipoprotein cholesterol (HDL-C) were found in the GCK-MODY group (1.5 +/- 0.27) compared with the T1D (1.2 +/- 0.47, p < 0.01) and T2D (1.3 +/- 0.3, p < 0.01) groups. On the other hand, a significantly lower LDL-C level (2.4 +/- 0.69) in the GCK-MODY group compared with the T1D (2.7 +/- 0.72, p < 0.01) and T2D (2.9 +/- 0.68, p < 0.01) groups was also noted. A lower ratio of triglyceride to HDL-C (TG/HDL) and a lower hsCRP level were also found in the GCK-MODY group [TG/HDL = 0.38 (0.25-0.52), hsCRP = 0.2 mg/L (0.16-0.37)] compared with the T1D group [(TG/HDL = 0.56 (0.39-1.29), hsCRP = 0.56 mg/L (0.39-1.29), p < 0.01] and the T2D group [(TG/HDL = 1.6 (1.1-2.68), hsCRP = 1.11 mg/L (0.66-2.34), p < 0.01]. Although patients with HNF1A-MODY showed similar hsCRP levels [0.17 (0.08-0.52), p > 0.05] compared with the patients in the GCK-MODY group, they had higher TG levels [1.01 (0.66-1.76), p < 0.05] and TG/HDL ratios [0.84 (0.56-1.31), p < 0.05]. Analysis of the correlations between the hsCRP levels and lipid profiles of each group confirmed that the LnhsCRP (natural logarithm-transformed hsCRP level) was positively correlated with the LnTG (natural logarithm-transformed TG) (r = 0.352, p = 0.011) and the Ln(TG/HDL) ratio (r = 0.283, p = 0.047) only in individuals with GCK-MODY. ConclusionsIndividuals harboring GCK variants have the characteristics of protective lipid profiles manifested as a higher level of HDL-C and a lower level of LDL-C compared with type 1 and 2 diabetes milletus (T1DM and T2DM, respectively) patients. In addition, lower ratios of TG/HDL were found to be associated with the inhibition of secretion of hsCRP, even when adjusted for the HbA1c levels in patients with GCK-MODY. It is suggested that the protective effect of macrovascular complications in GCK-MODY patients might partly be due to their unique lipid profiles associated with the suppression of inflammation.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Less but better: cardioprotective lipid profile of patients with GCK-MODY despite lower HDL cholesterol level
    Fendler, Wojciech
    Rizzo, Manfredi
    Borowiec, Maciej
    Malachowska, Beata
    Antosik, Karolina
    Szadkowska, Agnieszka
    Banach, Maciej
    Urbanska-Kosinska, Malgorzata
    Szopa, Magdalena
    Malecki, Maciej
    Mlynarski, Wojciech
    ACTA DIABETOLOGICA, 2014, 51 (04) : 625 - 632
  • [2] Identifying Patients with GDM at Risk for GCK-MODY
    Dickens, Laura T.
    Letourneau, Lisa R.
    Sanyoura, May
    Philipson, Louis H.
    Greeley, Siri Atma W.
    Naylor, Rochelle N.
    DIABETES, 2018, 67
  • [3] Less but better: cardioprotective lipid profile of patients with GCK-MODY despite lower HDL cholesterol level
    Wojciech Fendler
    Manfredi Rizzo
    Maciej Borowiec
    Beata Malachowska
    Karolina Antosik
    Agnieszka Szadkowska
    Maciej Banach
    Malgorzata Urbanska-Kosinska
    Magdalena Szopa
    Maciej Malecki
    Wojciech Mlynarski
    Acta Diabetologica, 2014, 51 : 625 - 632
  • [4] Prevalence of Retinopathy in Adult Patients with GCK-MODY and HNF1A-MODY
    Szopa, M.
    Wolkow, J.
    Matejko, B.
    Skupien, J.
    Klupa, T.
    Wybranska, I.
    Trznadel-Morawska, I.
    Kiec-Wilk, B.
    Borowiec, M.
    Malecki, M. T.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2015, 123 (09) : 524 - 528
  • [5] Quality of life assessment in patients with HNF1A-MODY and GCK-MODY
    Magdalena Szopa
    Bartlomiej Matejko
    Damian Ucieklak
    Agata Uchman
    Jerzy Hohendorff
    Sandra Mrozińska
    Wojciech Głodzik
    Barbara Zapała
    Teresa Płatek
    Iwona Solecka
    Cyrus M Sani
    Maciej T. Małecki
    Endocrine, 2019, 64 : 246 - 253
  • [6] Prevalence of retinopathy in adult patients with GCK-MODY and HNF1A-MODY
    Szopa, M.
    Wolkow, J.
    Matejko, B.
    Skupien, J.
    Klupa, T.
    Wybranska, I.
    Borowiec, M.
    Malecki, M. T.
    DIABETOLOGIA, 2015, 58 : S197 - S197
  • [7] Quality of life assessment in patients with HNF1A-MODY and GCK-MODY
    Szopa, Magdalena
    Matejko, Bartlomiej
    Ucieklak, Damian
    Uchman, Agata
    Hohendorff, Jerzy
    Mrozinska, Sandra
    Glodzik, Wojciech
    Zapala, Barbara
    Platek, Teresa
    Solecka, Iwona
    Sani, Cyrus M.
    Malecki, Maciej T.
    ENDOCRINE, 2019, 64 (02) : 246 - 253
  • [8] The influence of carbohydrate content of diet on glycaemia in GCK-MODY patients
    Klupa, T.
    Solecka, I.
    Nowak, N.
    Szopa, M.
    Borowiec, M.
    Mlynarski, W.
    Malecki, M. T.
    DIABETOLOGIA, 2010, 53 : S63 - S63
  • [9] The Influence of Carbohydrate Content of Diet on Glycemia in GCK-MODY Patients
    Klupa, Tomasz
    Solecka, Iwona
    Skupien, Jan
    Nowak, Natalia
    Szopa, Magdalena
    Malecki, Maciej T.
    DIABETES, 2010, 59 : A466 - A466
  • [10] Distinct Effects of a Novel GCK-MODY Mutation on Lipid Profiles and Diabetic Complications
    Huang, Yadi
    Fan, Yuxin
    Li, Xin
    Ji, Shuhui
    Chen, Shanshan
    Cui, Jingqiu
    Feng, Wenli
    Shu, Hua
    Liu, Ming
    DIABETES, 2023, 72